WntResearch Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 0/6
WntResearch's earnings have been declining at an average annual rate of -8.3%, while the Biotechs industry saw earnings growing at 7.7% annually.
Wichtige Informationen
-8.3%
Wachstumsrate der Gewinne
48.8%
EPS-Wachstumsrate
| Biotechs Wachstum der Industrie | 0.7% |
| Wachstumsrate der Einnahmen | n/a |
| Eigenkapitalrendite | -149.1% |
| Netto-Marge | n/a |
| Nächste Ertragsaktualisierung | 21 Nov 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Aufschlüsselung der Einnahmen und Ausgaben
Wie WntResearch Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Jun 24 | 0 | -41 | 42 | 0 |
| 31 Mar 24 | 0 | -36 | 37 | 0 |
| 31 Dec 23 | 0 | -32 | 33 | 0 |
| 30 Sep 23 | 0 | -31 | 31 | 0 |
| 30 Jun 23 | 0 | -30 | 30 | 0 |
| 31 Mar 23 | 0 | -30 | 30 | 0 |
| 31 Dec 22 | 0 | -31 | 30 | 0 |
| 30 Sep 22 | 0 | -38 | 37 | 0 |
| 30 Jun 22 | 0 | -38 | 38 | 0 |
| 31 Mar 22 | 0 | -39 | 38 | 0 |
| 31 Dec 21 | 0 | -36 | 35 | 0 |
| 30 Sep 21 | 0 | -28 | 28 | 0 |
| 30 Jun 21 | 0 | -25 | 25 | 0 |
| 31 Mar 21 | 0 | -21 | 20 | 0 |
| 31 Dec 20 | 0 | -22 | 21 | 0 |
| 30 Sep 20 | 0 | -23 | 23 | 0 |
| 30 Jun 20 | 0 | -26 | 25 | 0 |
| 31 Mar 20 | 0 | -27 | 27 | 0 |
| 31 Dec 19 | 0 | -25 | 25 | 0 |
| 30 Sep 19 | 0 | -29 | 28 | 0 |
| 30 Jun 19 | 0 | -27 | 26 | 0 |
| 31 Mar 19 | 0 | -25 | 25 | 0 |
| 31 Dec 18 | 0 | -24 | 24 | 0 |
| 30 Sep 18 | 0 | -20 | 19 | 0 |
| 30 Jun 18 | 0 | -22 | 21 | 0 |
| 31 Mar 18 | 0 | -30 | 29 | 0 |
| 31 Dec 17 | 0 | -35 | 34 | 0 |
| 30 Sep 17 | 0 | -34 | 33 | 0 |
| 30 Jun 17 | 0 | -31 | 30 | 0 |
| 31 Mar 17 | 0 | -25 | 25 | 0 |
| 31 Dec 16 | 0 | -20 | 20 | 0 |
| 30 Sep 16 | -11 | -29 | 18 | 0 |
| 30 Jun 16 | -5 | -25 | 20 | 0 |
| 31 Mar 16 | -3 | -20 | 17 | 0 |
| 31 Dec 15 | 0 | -18 | 18 | 0 |
| 30 Sep 15 | 14 | -4 | 18 | 0 |
| 30 Jun 15 | 11 | -4 | 15 | 0 |
| 31 Mar 15 | 10 | -7 | 17 | 0 |
| 31 Dec 14 | 8 | -7 | 15 | 0 |
| 30 Sep 14 | 8 | -6 | 14 | 0 |
| 30 Jun 14 | 5 | -6 | 11 | 0 |
| 31 Mar 14 | 4 | -4 | 8 | 0 |
| 31 Dec 13 | 5 | -4 | 9 | 0 |
Qualität der Erträge: WNT is currently unprofitable.
Wachsende Gewinnspanne: WNT is currently unprofitable.
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: WNT is unprofitable, and losses have increased over the past 5 years at a rate of 8.3% per year.
Beschleunigtes Wachstum: Unable to compare WNT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Erträge im Vergleich zur Industrie: WNT is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-20.8%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: WNT has a negative Return on Equity (-149.14%), as it is currently unprofitable.